# The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial

> **NCT03209258** · NA · COMPLETED · sponsor: **The George Institute for Global Health, China** · enrollment: 7067 (actual)

## Conditions studied

- Cerebral Hemorrhage
- Stroke
- Hypertension
- Diabetes
- Anticoagulant-induced Bleeding
- Cerebral Vascular Disorder
- Brain Disorder
- Hemorrhage
- Intracranial Hemorrhages
- Cardiovascular Diseases
- Central Nervous System Diseases

## Interventions

- **OTHER:** Care bundle of active management
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT03209258
- **Lead sponsor:** The George Institute for Global Health, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-12
- **Primary completion:** 2022-10-12
- **Final completion:** 2022-11-17
- **Target enrollment:** 7067 (ACTUAL)
- **Last updated:** 2022-11-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03209258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03209258, "The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03209258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
